We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Apotex Breaks From Pack With Scathing Critique of Pay-for-Delay
Apotex Breaks From Pack With Scathing Critique of Pay-for-Delay
February 15, 2013
In a self-acknowledged deviation from both its generic counterparts and the brand pharmaceutical industry, Apotex has called on the U.S. Supreme Court to overturn an 11th Circuit Court decision that upheld the legality of reverse patent settlements between brand drugmakers and generic competitors.